Cargando…

Identifying very low-risk STEMI patients for early ICU discharge in the COVID-19 era

Detalles Bibliográficos
Autores principales:	Altisent, Omar Abdul-Jawad, Carrillo, Xavier, Puri, Rishi, Bayés-Genís, Antoni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Letter to the Editors
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356109/ https://www.ncbi.nlm.nih.gov/pubmed/32661674 http://dx.doi.org/10.1007/s00392-020-01702-0

Ejemplares similares

Caval Valve Implantation (CAVI): An Emerging Therapy for Treating Severe Tricuspid Regurgitation
por: Abdul-Jawad Altisent, Omar, et al.
Publicado: (2021)

Advanced remote care for heart failure in times of COVID-19 using an implantable pulmonary artery pressure sensor: the new normal
por: Bayes-Genis, Antoni, et al.
Publicado: (2020)

Prognostic Value of New‐Generation Troponins in ST‐Segment–Elevation Myocardial Infarction in the Modern Era: The RUTI‐STEMI Study
por: Cediel, Germán, et al.
Publicado: (2017)

Non-STEMI vs. STEMI Cardiogenic Shock: Clinical Profile and Long-Term Outcomes
por: Martínez, María José, et al.
Publicado: (2022)

A Novel Protocol for Very Early Hospital Discharge After STEMI
por: Marbach, Jeffrey A., et al.
Publicado: (2020)

Translational proteomics in cardiogenic shock: from benchmark to bedside
por: Iborra-Egea, Oriol, et al.
Publicado: (2022)

Conduction Disorders in the Setting of Acute STEMI
por: Nikus, Kjell, et al.
Publicado: (2021)

Acute Coronary Syndromes in 2011 and 2012
por: Sanchis, Juan, et al.
Publicado: (2013)

Short- and Long-Term Mortality Trends in STEMI-Cardiogenic Shock over Three Decades (1989–2018): The Ruti-STEMI-Shock Registry
por: García-García, Cosme, et al.
Publicado: (2020)

The role and potential of umbilical cord blood in an era of new therapies: a review
por: Roura, Santiago, et al.
Publicado: (2015)

Heart Failure Treatment by Device
por: Bayés-Genis, Antoni
Publicado: (2020)

The DELIVER Trial: the Beginning of the End of Ejection Fraction Tyranny
por: Bayes-Genis, Antoni
Publicado: (2022)

COVID-19 sends STEMI to quarantine!?
por: Abdi, Seifollah, et al.
Publicado: (2020)

Compelling Benefit of Soluble Suppression of Tumorigenicity‐2 in Post–Myocardial Infarction Estimation of Risk: The Time Is Right for Its Routine Use in the Clinic
por: Díez, Javier, et al.
Publicado: (2017)

Use of a noninvasive ventilation device following tracheotomy: an alternative to facilitate ICU discharge?
por: Blanco, Jacobo Bacariza, et al.
Publicado: (2013)

de Winter sign–A STEMI Equivalent
por: Mahajan, Kunal, et al.
Publicado: (2018)

The Challenge of Managing STEMI in the COVID-19 Epidemic
por: Jolobe, Oscar M.P.
Publicado: (2021)

Assessment of sepsis-induced immunosuppression at ICU discharge and 6 months after ICU discharge
por: Zorio, Violette, et al.
Publicado: (2017)

Is red blood cell distribution width a marker of severity in patients discharged from the ICU?
por: Tonietto, Tiago Antonio, et al.
Publicado: (2019)

Sacubitril/valsartan affects pulmonary arterial pressure in heart failure with preserved ejection fraction and pulmonary hypertension
por: Codina, Pau, et al.
Publicado: (2022)

STEMI or non-STEMI: that is the question
por: Camaro, Cyril, et al.
Publicado: (2015)

Simultaneous multiple coronary arteries thrombosis in patients with STEMI
por: Kim, Seunghwan, et al.
Publicado: (2018)

Transradial versus transfemoral approach in STEMI: Choice is with the operator
por: Deora, Surender
Publicado: (2020)

COVID-19—Where Have All the STEMIs Gone?
por: Tanner, Richard, et al.
Publicado: (2020)

Plato's allegory of the cave and the paradigm of complete revascularization in STEMI
por: Justo, Fernanda A., et al.
Publicado: (2022)

Can Natriuretic Peptides be Used to Guide Therapy?
por: Bayes-Genis, Antoni, et al.
Publicado: (2016)

Characterization and management of cognitive and emotional alterations in COVID-19 critically ill patients after ICU discharge
por: Navarra-Ventura, G., et al.
Publicado: (2022)

Characterization and management of cognitive and emotional alterations in COVID-19 critically ill patients after ICU discharge
por: Navarra-Ventura, G., et al.
Publicado: (2022)

Thrombolysis in STEMI in the era of COVID – Holding fort in cardiologist deficit locales
por: Karanth, Jnanaprakash B., et al.
Publicado: (2023)

Surface ECG interatrial block-guided treatment for stroke prevention: rationale for an attractive hypothesis
por: Bayés de Luna, Antoni, et al.
Publicado: (2017)

“Back to the Future” for STEMI?: The COVID-19 Experience
por: Riley, Robert F., et al.
Publicado: (2020)

New guidelines on primary PCI for patients with STEMI: changing insights
por: van der Wall, E.E.
Publicado: (2015)

Delayed asymptomatic progressive aortic dissecting aneurysm in patient with STEMI
por: Song, Yun-Seok, et al.
Publicado: (2017)

Are mesenchymal stem cells and derived extracellular vesicles valuable to halt the COVID-19 inflammatory cascade? Current evidence and future perspectives
por: Monguió-Tortajada, Marta, et al.
Publicado: (2021)

Intracoronary pharmacological therapy versus aspiration thrombectomy in STEMI (IPAT-STEMI): A systematic review and meta-analysis of randomized trials
por: Kaddoura, Rasha, et al.
Publicado: (2022)

Bioluminescence imaging: a shining future for cardiac regeneration
por: Roura, Santiago, et al.
Publicado: (2013)

Different Effects on Protein Expression of CDR132L, an Antisense Inhibitor of miR-132, and Standard Therapies for Myocardial Infarction
por: Iborra-Egea, Oriol, et al.
Publicado: (2022)

Impact of customised ICU handover protocol on the quality of ICU discharge reports
por: Correia, Paulo César, et al.
Publicado: (2022)

Trends and Outcomes of Fibrinolytic Therapy for STEMI: Insights and Reflections in the COVID-19 Era
por: Elbadawi, Ayman, et al.
Publicado: (2020)

Concerns for management of STEMI patients in the COVID-19 era: a paradox phenomenon
por: Vlachakis, Panayotis K., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_avcaeqas7lf1dflkeorebe4ahi